Green Bay Packers running back Ahman Green's 90-yard touchdown run against the Dallas Cowboys is among the five Week 7 nominees for the "LEVITRA? (vardenafil HCI) PLAY OF THE WEEK."
The award is presented each Thursday during the NFL regular season to recognize the single most exciting play that week as determined by the fans. Voting is open to the fans each week from Tuesday at Noon ET until Thursday at Noon ET, exclusively on NFL.com. Each weekly winner will be a finalist for the "LEVITRA? PLAY OF THE YEAR," to be awarded at Super Bowl XXXIX in Jacksonville, Florida.
Fans who vote at NFL.com each week can also enter for their chance to win a three-day/two-night trip for two to Jacksonville, Florida to attend Super Bowl XXXIX on February 6, 2005, including round-trip airfare and hotel accommodations.
Pittsburgh Steelers defensive tackle Kimo von Oelhoffen's 21-yard fumble return that set up the game-winning touchdown against the Dallas Cowboys was voted last week's winner of the "LEVITRA? PLAY OF THE WEEK" by the fans on NFL.com.
For details and video of this week's nominees, past winners and the results of fan voting, log onto NFL.com.
In July 2003, Bayer Pharmaceutical Corporation (Bayer) & GlaxoSmithKline (GSK), co-marketers of LEVITRA (vardenafil HCI), a prescription medicine that is used to treat erectile dysfunction (ED), announced their groundbreaking sponsorship of the NFL.
Week #7 Nominees
Ahman Green, RB- Green Bay Packers, 90-yard touchdown run
With his team leading by the score of 34-10, Green Bay running back Ahman Green took a Brett Favre handoff, sliced through a hole and outran the Dallas Cowboys defense for a 90-yard score, capping the third-longest run in team history. Green recorded 163 yards on 15 carries and scored twice in Green Bay's 41-20 win.
Gerald Hayes, LB- Arizona Cardinals, Blocked punt for safety
With the Arizona Cardinals trailing by one point, Cardinals linebacker Gerald Hayes burst through the line and blocked a Seattle punt. The ball rolled into the end zone and was batted out of bounds for a safety. Hayes' play put Arizona ahead 18-17 and proved to be the decisive points in the Cardinals 25-17 victory over the Seahawks.
Randy McMichael, TE- Miami Dolphins, 42-yard touchdown reception
With less than a minute to play in the first half and Miami facing third and long, Dolphins quarterback Jay Fiedler zipped a pass to tight end Randy McMichael, who streaked down the middle of the field for a 42-yard touchdown. The play broke a 7-7 tie and helped propel the Dolphins to their first win of the season, a 31-14 victory over the St. Louis Rams.
Deion Sanders, CB- Baltimore Ravens- 48-yard interception return for a touchdown
With 1:48 left in the opening quarter of a 3-3 game with the Buffalo Bills, Baltimore Ravens cornerback Deion Sanders grabbed a deflected pass out of the air and returned it 48 yards for a touchdown. Sanders would add his second interception later in the game as the Ravens went on to defeat the Bills 20-6.
Josh Scobee, K- Jacksonville Jaguars- 53-yard game-winning field goal
With less then a minute left in regulation of the Jacksonville Jaguars divisional match-up with the Indianapolis Colts, Jaguars rookie kicker Josh Scobee kicked a game-winning 53-yard field goal. The 27-24 victory over Indianapolis, moved the Jaguars into first place in the AFC South and snapped the Colts' four-game winning streak.
LEVITRA is a prescription medicine that is used to treat erectile dysfunction (ED). Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take LEVITRA. Men who use alpha blockers, sometimes prescribed for high blood pressure or prostate problems, also should not take LEVITRA. Such combinations could cause blood pressure to drop to an unsafe level.
You should not take LEVITRA if your doctor determines that sexual activity poses a health risk for you. Men who experience an erection for more than four hours should seek immediate medical attention. LEVITRA does not protect against sexually transmitted diseases.
The starting dose of LEVITRA is 10 mg taken no more than once per day. Your doctor will decide the dose that is right for you. In patients taking certain medications such as ritonavir, indinavir, ketoconazole, itraconazole, and erythromycin, lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended.
In clinical trials, the most commonly reported side effects were headache, flushing, and stuffy or runny nose. LEVITRA is available in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets.
About Erectile Dysfunction
The consistent or recurrent inability of a man to attain and/or maintain a penile erection sufficient for sexual performance1 - is a common health condition among men that is largely untreated. It is estimated that some degree of ED affects more than one half of all men over the age of 402- 152 million men worldwide3 and 30 million men in the United States alone.4
Despite the high prevalence of sexual problems, nine out of 10 men in the U.S. have not yet sought treatment from a physician.5
- Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Societe Internationale d'Urologie (SIU) and held July 1-3, 1999, Paris. 2000, p. 713.
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
- Aytac IA, McKinlay JB, Krane RI. The likely worldwide increase of erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-56
- National Institutes of Health, Consensus Development Conference Statement, December 7-9, 1992. Online data: http://odp.od.nih.gov/consensus/cons/091/091_statement.htm. (accessed 8/26/02).
- Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
About Bayer Pharmaceuticals Corporation
Bayer Pharmaceuticals Corporation (www.bayerpharma.com) is part of the worldwide operations of Bayer HealthCare AG, a subgroup of Bayer AG. Bayer HealthCare, with sales of approximately 8.9 billion Euro in 2003, is one of the world's leading, innovative companies in the health care and medical products industry. The company combines the global activities of the divisions Animal Health, Biological Products, Consumer Care, Diagnostics Professional Testing Systems and Diagnostics Self Testing Systems and Pharmaceuticals. 34,600 people are employed by Bayer HealthCare worldwide.
Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease.
Forward Looking Statement
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including its Form 20-F). Bayer assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
For more information about LEVITRA, please visit www.LEVITRA.com.